Ignite Creation Date:
2024-05-05 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00006591
Status:
UNKNOWN
Last Update Posted:
2005-06-24
First Post:
2000-12-01
Brief Title:
Ritonavir and Agenerase Treatment for Patients Who Have Failed Previous Anti-HIV Treatment
Sponsor:
Gathe Joseph MD
Organization:
NIH AIDS Clinical Trials Information Service
Study Overview
Official Title:
The Safety and Efficacy of a Ritonavir-Enhanced Agenerase Regimen as Salvage Therapy in HIV-Infected Individuals
Status:
UNKNOWN
Status Verified Date:
2004-12
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine if treatment with an anti-HIV drug containing ritonavir and Agenerase is safe and can lower the level of HIV in the blood in patients who have failed an anti-HIV drug treatment containing nelfinavir
Detailed Description:
HIV-infected patients will be treated with a ritonavir-enhanced Agenerase regimen
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| APV-430 | None | None | None |